US 2017/0249444 A1 · Gradual and Individualized Transitions between Drug Delivery Protocols in an Ambulatory Drug Delivery System

Abstract

A drug infusion system located at least partially external to the patient having a pump and an external patient programmer control configured to allow adjustment of therapy. Adjustment may include setting, selecting and adjusting the transition period between drug delivery rates. The system can present to the patient an alert related to the adjustment and receive patient input information in response thereto. A patient response rule module is configured to apply a rule to the input information provided by a patient. For example, the patient response rule can be used to provide an insulin pump setting according to the patient response rule or to provide a setting, or to provide a setting that is proposed to the user. Other systems and methods are also described such as asking questions related to the adjustment of future therapy settings.

Claims20

Dependent claims

A system for delivering medication to a patient, comprising:

a drug infusion system having a pump under control of a processor;
and
software associated with the pump configured to automatically provide a medication dose regimen of a treatment protocol that is based upon input from a user, the medication dose regimen comprising
at least two delivery rates;
a first duration for delivering a medication to the patient at a first delivery rate;
and
a second duration for delivering the medication at a second delivery rate;
and
at least one transition period during which a delivery rate gradually transitions between at least the first and second rates.

6 more elements

Dependencies are inferred from the claim text.

Facts

Application

15/594,626Filed 14 May 2017

Priority

31 Aug 2005

Published

31 Aug 2017

Term ends

Not estimatedThe source records don’t support an estimate.

Classification28 codes

A61B 5/4809
Sleep evaluation: sleep detection, i.e. determining whether a subject is asleep or not
A61B 5/4082
Diagnosing or monitoring particular conditions of the nervous system: diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or…
A61M 5/142
Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor: pressure infusion, e.g. using pumps
A61M 5/14276
Adapted to be carried by the patient, e.g. portable on the body: specially adapted for implantation

Family

Application60/596,095Us provisional application · filed 31 Aug 2005

Application60/596,693Us provisional application · filed 13 Oct 2005

Application11/309,605Continuation in part · filed 30 Aug 2006

Application60/862,799Us provisional application · filed 25 Oct 2006

Application11/877,897Continuation · filed 24 Oct 2007

Application14/715,995Continuation · filed 19 May 2015

Application15/180,694Continuation · filed 13 Jun 2016

Application15/594,626Continuation

Application11/877,897Continuation in part

US 2008/0058773 A1Published application

US 2008/0288023 A1Published application

US 2015/0273223 A1Published application

US 2016/0303322 A1Published application

US 9,089,713 B2Related patent

US 9,364,679 B2Related patent

US 9,649,439 B2Related patent

US 2017/0249444 A1This patent

From the US filing history. Foreign family members aren’t listed.

Gradual and Individualized Transitions between Drug Delivery Protocols in an Ambulatory Drug Delivery System

Life of this patent

Gradual and Individualized Transitions between Drug Delivery Protocols in an Ambulatory Drug Delivery System

Life of this patent

Abstract

Claims20